Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,294,171
+$2,806,490 QoQ
Shares Held
635,140
+42.8% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#341
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $371,290,075 across 10 Drug Manufacturers - General names. PFE ranks #7 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
90,318 | $108,330,127 | |
| 2 | JNJ |
Johnson & Johnson
|
265,811 | $67,508,019 | |
| 3 | ABBV |
AbbVie Inc.
|
206,756 | $52,028,079 | |
| 4 | AMGN |
Amgen Inc
|
109,431 | $39,627,153 | |
| 5 | MRK |
Merck & Co., Inc.
|
273,534 | $35,149,119 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
264,468 | $33,412,887 | |
| 7 | PFE |
Pfizer Inc
This page
|
635,140 | $15,294,171 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
228,360 | $13,158,103 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,294,171 | 635,140 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,487,681 | 444,718 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,468,303 | 621,217 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $16,305,492 | 639,933 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $14,802,665 | 610,671 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,617,513 | 537,392 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $17,423,418 | 656,744 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $17,066,988 | 589,737 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $17,653,757 | 630,942 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $16,687,573 | 601,354 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $16,957,828 | 589,018 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $19,897,820 | 599,874 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $20,341,370 | 554,563 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $20,764,548 | 508,935 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $25,037,349 | 488,629 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $13,364,610 | 305,407 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,386,285 | 140,879 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $9,331,956 | 180,258 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $12,108,970 | 205,063 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $8,411,422 | 195,569 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $5,314,951 | 135,724 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $4,239,670 | 117,021 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $3,835,749 | 104,204 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $4,074,796 | 111,030 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,380,660 | 133,965 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $1,811,027 | 55,485 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||